Page last updated: 2024-10-21

2,2'-azobis(2-amidinopropane) and Anemia, Hemolytic

2,2'-azobis(2-amidinopropane) has been researched along with Anemia, Hemolytic in 1 studies

2,2'-azobis(2-amidinopropane): water-soluble free-radical initiator

Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).

Research Excerpts

ExcerptRelevanceReference
"The extension of hemolysis is variable with erythrocyte samples, but 12."5.31Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure. ( Almeida, LM; Cruz Silva, MM; Custódio, JB; Madeira, VM, 2000)
"The extension of hemolysis is variable with erythrocyte samples, but 12."1.31Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure. ( Almeida, LM; Cruz Silva, MM; Custódio, JB; Madeira, VM, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cruz Silva, MM1
Madeira, VM1
Almeida, LM1
Custódio, JB1

Other Studies

1 other study available for 2,2'-azobis(2-amidinopropane) and Anemia, Hemolytic

ArticleYear
Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure.
    Biochimica et biophysica acta, 2000, Mar-15, Volume: 1464, Issue:1

    Topics: Adult; Amidines; Anemia, Hemolytic; Cells, Cultured; Dose-Response Relationship, Drug; Erythrocyte M

2000